Fecal microbiota transplantation for patients with active ulcerative colitis: A cost‐effectiveness analysis-Reference-Cited by-同舟云学术

Fecal microbiota transplantation for patients with active ulcerative colitis: A cost‐effectiveness analysis

Published:2022-10-09 Issue:1 Volume:38 Page:70-78
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Yao Jiaqi¹,Fekadu Ginenus¹,Ng Siew C²³^ORCID,You Joyce H S¹^ORCID

Affiliation:

1. School of Pharmacy, Faculty of Medicine The Chinese University of Hong Kong Hong Kong

2. Microbiota I‐Center The Chinese University of Hong Kong Hong Kong

3. Department of Medicine and Therapeutics, LKS Institute of Health Science, State Key Laboratory of Digestive Disease The Chinese University of Hong Kong Hong Kong

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.16015

Reference50 articles.

1. Ulcerative colitis

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

3. Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years — United States, 2015

4. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States

5. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between washed microbiota transplantation and infliximab: Medical cost during long-term management in patients with inflammatory bowel disease;Journal of the Chinese Medical Association;2023-11-21

2. Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis;Scientific Reports;2023-09-03

3. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion;Journal of Nanobiotechnology;2023-08-31

4. Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis;2023-06-09